+ Follow CLINICAL THERAPEUTICS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 362584
[Title] => Hypertension drug gets BFAD approval
[Summary] => Its now official. A new brand of amlodipine camsylate will soon be available in the market, courtesy of Therapharma Inc, a division of United Laboratories (Unilab).
The Bureau of Food and Drugs recently granted a certificate of product registration for the new brand of amlodipine.
The BFAD conducted a stringent evaluation of all documents and samples of the new brand of amlodipine to assess its efficacy and safety and the issuance of its certificate of product registration indicates that it has passed all tests for efficacy and safety.
[DatePublished] => 2006-10-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
CLINICAL THERAPEUTICS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 362584
[Title] => Hypertension drug gets BFAD approval
[Summary] => Its now official. A new brand of amlodipine camsylate will soon be available in the market, courtesy of Therapharma Inc, a division of United Laboratories (Unilab).
The Bureau of Food and Drugs recently granted a certificate of product registration for the new brand of amlodipine.
The BFAD conducted a stringent evaluation of all documents and samples of the new brand of amlodipine to assess its efficacy and safety and the issuance of its certificate of product registration indicates that it has passed all tests for efficacy and safety.
[DatePublished] => 2006-10-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
October 12, 2006 - 12:00am